Enlarge/ An organic brain is a small organ that produces and secures signals from other parts of the body.
It’s similar to the brain in a human, but has fewer connections and functions.
Brain boosters, however, have been around for decades.
But a new study finds they are getting less attention as research becomes more precise.
The study was done by researchers at the University of California, Berkeley, and is published in the journal Proceedings of the National Academy of Sciences.
They say the brain booster has been found in at least two other laboratories, and that other methods have failed to show results.
But the researchers say the lack of attention is a problem that they are addressing.
“We are seeing a lot of people trying to make this stuff into an intervention, and they are making very big claims that the brain has a higher capacity than it does,” said lead author John Schulze, a postdoctoral fellow in neurobiology at the UC Berkeley.
“There are so many other ways to measure it.”
Schulz says the current studies using a technique called diffusion tensor imaging (DTI) are not sufficient to identify whether a brain booster increases or decreases the amount of signals it produces.
For this study, the researchers used diffusion tensors to measure the volume of the brain and the volume in the cerebellum, the area that sits between the two brain hemispheres.
DTI measures the number of molecules that are carried from one place to another.
These measurements are useful for identifying the presence of brain cells in different parts of a brain.
Schulze said the DTI technique is a bit like looking at a single molecule that is carried from the brain to the cerebrospinal fluid, or CSF, which is a part of the blood.
In this study the researchers focused on the cerebrum, which contains the cerebrain and two smaller brain regions, the hippocampus and prefrontal cortex.
If the researchers could identify the diffusion tensoring signal that a brain boosters produced, they could look at how much the brain boosts the amount in each part of a cerebellar region.
This would provide more accurate information about how much brain activity a brain stimulator can help to boost, Schulzes said.
That information could also help researchers figure out how much stimulation a brain stimulation can provide in the brain.
For example, the team is planning to use the results to figure out whether it is possible to use a brain stimulant to increase activity in a region of the cerebral cortex that is linked to memory and learning.
Another question that the researchers are interested in is whether a small amount of brain stimulation could help with certain types of cognitive problems.
For instance, one study showed that using brain boosters could improve the ability to pay attention in a task.
But Schults team is also looking into the possibility that they could use this data to help people who have Alzheimer’s disease, a common form of dementia.
While Schulzi said the study was just a proof of concept, the findings could help researchers make predictions about how to use brain stimulation to improve memory and concentration.
Other recent research shows that people who are already taking brain stimulants for a cognitive problem are not affected by a brain-boosting effect, which could help to explain why brain boosters are not being used in clinical trials to help patients with Alzheimer’s.
Scientists also are working on ways to use DTI to identify and block brain growth in older people.
For the current study, researchers scanned the brains of elderly people with Alzheimer the brain had been damaged.
Researchers also found that a group of people who were already taking a brain enhancer, called an adenosine receptor antagonist, had reduced brain size, even though they had no evidence of a decrease in brain activity.
Those findings are encouraging, Schuls said, but he noted that the results do not prove that using a brain implant or a brain boosting medication is effective for dementia.
“I am hopeful that these findings will lead to more evidence-based interventions for dementia and Alzheimer’s,” he said.
“But I do worry about the potential for the brain enhancers to become so widely used that we have to have a moratorium on using them.”
More from Science Daily: